Pharmaceutical Technology

APRIL 20, 2023

Targovax has unveiled plans to rebrand as Circio , reflecting its strategic shift to focus on expediting the development of its innovative circular RNA (circRNA) platform. Circio aims to develop new circRNA medicines initially for cancer, then plans to expand rapidly into vaccines and gene therapy.

Vaccines 96

Vaccines 96

Pharmaceutical Technology

MAY 3, 2023

BrightPath Biotherapeutics and Artisan Bio have signed a research and licensing agreement to expedite the former’s allogeneic next-generation invariant natural killer T (iNKT) cell therapies to clinic. Artisan will receive an upfront payment and research milestone payments, along with licence fees and development milestones from BrightPath.

52

52

Pharmaceutical Technology

AUGUST 25, 2022

Sonoma Biotherapeutics has signed a lease agreement for setting up an 83,000ft² research and development (R&D) and manufacturing centre for cell therapies. The centre is also expected to provide engineering, scientific and manufacturing job opportunities in the Seattle region.

Immunization 52

Immunization 52

Pharmaceutical Technology

MAY 31, 2023

The company is also looking at developing therapies based on individual patient neoantigens in patient human leukocyte antigens (HLAs). Anocca’s platform features libraries of engineered human cells that allow for standardised analysis of T-cell biology, per the company’s website.

Vaccines 52

Vaccines 52

ISPE

SEPTEMBER 8, 2023

Ganguly has been a Facility of the Year Award (FOYA) judge and served on the Global Pharmaceutical Manufacturing Leadership Forum; he has also been published in Pharmaceutical Engineering® and was awarded the 2006 ISPE Roger F. Why Do You Think Professional Development Is Important? Sherman Article of the Year Award.

52

52

Pharmaceutical Technology

MARCH 8, 2023

The multi-year collaboration aims to develop new technologies which will help in improving clinical outcomes for patients. The new technologies will also overcome the manufacturing bottlenecks in delivering advanced engineered cell products. The programme aims to develop advanced technologies and applications to improve human health.

Communication 97

Communication FDA 97

Pharmaceutical Technology

FEBRUARY 23, 2023

Moderna has entered a strategic research and development partnership with ElevateBio’s Life Edit Therapeutics to discover and develop new in-vivo mRNA gene editing therapies. Under the deal, both companies will partner on the research and preclinical studies, which will be funded by Moderna.

Communication 59

Communication 59

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination.

121

121

Pharmaceutical Technology

JUNE 9, 2023

The site has been involved in the development, manufacture and testing of clinical and commercial medicines. Each engineered T cell batch is manufactured separately and infused back into the cancer patient. The company operates two further research and development facilities in Cambridge, Massachusetts.

FDA 52

FDA 52

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. In the pharmaceutical industry, content marketing can be particularly effective for driving sales.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

NOVEMBER 29, 2022

For several decades, researchers have been investigating the role of ketamine in treating depression. On November 14, the Canadian developer PharmaTher announced positive data from a Phase I/II study where ketamine was used to treat levodopa-induced dyskinesia in Parkinson’s disease. PharmaTher is not the only player in this space.

Pharmaceutical Companies 110

Pharmaceutical Companies Pharmaceutical Companies Labelling FDA 110

ISPE

FEBRUARY 7, 2023

The two-day conference on 31 January–1 February featured a range of sessions on topics including biomanufacturing, cell and gene therapy, digital transformation and Pharma 4.0™, Hartman noted the importance of attendees’ work in bringing pharmaceuticals to patients. ™, emerging technologies, and facility design and construction.

Vaccines 88

Vaccines Dosage Hospitals 88

pharmaphorum

OCTOBER 2, 2020

The five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects. The webinar will also cover: What the NPRCs’ franchise model means for research delivery.

Hospitals 92

Hospitals 92

Pharmaceutical Technology

JANUARY 10, 2023

Boehringer Ingelheim has entered a strategic partnership and licensing agreement with 3T Biosciences for the discovery and development of next-generation cancer immunotherapies. The company will receive an undisclosed upfront payment and research and development support. Free Whitepaper.

Immunization 52

Immunization Compounding Communication 52

Pharmaceutical Technology

DECEMBER 14, 2022

Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications. The firms intend to merge their expertise to provide simplified viral vector gene therapy development, production and testing in Japan. Free Whitepaper.

Communication 52

Communication 52

Hospital Pharmacy Europe

AUGUST 17, 2023

In CAR T-cell therapy, which is classified as an advanced therapy medicinal product, autologous T-cells are genetically engineered ex vivo to express CARs that direct the patient’s lymphocytes to kill the tumour cells. The engineered cells are expanded in a dedicated production facility and then administered via infusion to the patient.

Hospitals 98

Hospitals Documentation Chemotherapy Pharmaceutical Companies 98

Viseven

JANUARY 13, 2023

Without such an assessment, it would be too risky to launch new products into development or even enter a new market. So what do exactly HEOR experts do for the pharmaceutical companies and what HEOR-collected data is used for? How HEORs Contribute to Research? What does Health Economics and Outcomes Research do?

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Documentation 40

pharmaphorum

OCTOBER 2, 2020

The five new NHS Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects. The webinar will also cover: What the NPRCs’ franchise model means for research delivery.

Hospitals 52

Hospitals 52

ISPE

SEPTEMBER 28, 2023

It's no wonder that global pharmaceutical companies are increasingly sourcing innovation through alliances and partnerships with their peers in California. million residents have graduate degrees – as well as an array of workforce development initiatives, focused on life sciences careers. Management WoF

Hospitals 98

Hospitals Documentation Pharmaceutical Companies Pharmaceutical Companies 98

ISPE

NOVEMBER 10, 2022

This workshop was organized by the ISPE NL EL Community of Practice (CoP) within the Life Science & Health Career Event hosted by Federation of Innovative Medicines Research in the Netherlands (FIGON) Dutch Medicine Days and Annual Conference of EUFEPS. Roel Nieuwenhuis (GAMP representative; Validation Engineer at Astellas Pharma).

52

52

pharmaphorum

OCTOBER 12, 2020

Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity. Sakshi Garg, Lab Head, Discovery & Development Technologies, Merck Group.

Immunization 52

Immunization 52

ISPE

OCTOBER 26, 2022

Eighty percent of Chapters and Affiliates have embraced the concepts that improve the interactions, promote growth of membership, and incentivize the involvement of students in ISPE, which is a topic that is very close to my heart. Thank you, Tim!

Packaging 52

Packaging Compounding Communication Vaccines 52

ISPE

NOVEMBER 1, 2022

Vice President, Vetter Development Service, External Affairs. Zipp spoke next to welcome attendees, who she encouraged to make the most of the meeting through sessions and meeting with colleagues, noting that many key topics are being covered. He presented on “Quality: A Key Ingredient for Stable Pharmaceutical Supply Chains.”.

FDA 98

FDA Insurance Chemotherapy Documentation 98

Viseven

OCTOBER 26, 2022

The pharmaceutical industry still faces significant challenges and is looking for innovative solutions. Below are five of the most significant pharmaceutical industry problems. . Therefore, to reduce the challenges of their pharmaceutical supply chain, they changed their strategy and made the most use of the resources available.

Hospitals 52

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

NOVEMBER 11, 2020

Arteric’s Lexical analysis involved an Arteric proprietary machine learning application called the Word Embedding Engine (WEE) that rapidly and efficiently analyzed 3,000 web pages to uncover rich competitive insights about competitors’ brand and content strategies. Pharma Marketing 2020: The Enduring Impact .

Communication 52

Communication 52

ISPE

JANUARY 11, 2023

Life-Cycle Approach to Cleaning Topical Drug Products Trudy Patterson Wed, 01/11/2023 - 10:17 Technical January / February 2023 Life-Cycle Approach to Cleaning Topical Drug Products Dijana Hadziselimovic Kamini I. However, some of the products manufactured in a topical drug facility can be difficult to clean. Lopolito Steven M.

Method Validation 52

Method Validation Documentation Packaging Compounding 52

PharmaShots

MARCH 6, 2023

Traditionally patients were viewed by pharmaceutical companies as simply users of our products, nowadays they are considered partners working towards a collective goal. As a result of this progression, our industry developed the notion of patient-centricity. Smriti: Give our readers a brief detail about UCB’s Innovators campaign.

Immunization 40

Immunization Pharmaceutical Companies Pharmaceutical Companies Hospitals 40

ISPE

JULY 10, 2023

ChatGPT : “Yes, ChatGPT can be useful in regulated areas of the pharmaceutical industry, such as providing information on drug products, their uses, dos-ages, side effects, and interactions with other medications. Specific aspects of pharmaceutical roles (e.g., quality assurance) are not mentioned here.

Labelling 52

Labelling Documentation Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

OCTOBER 27, 2022

As digital health sits at the intersection of technical, scientific, and regulatory disciplines involving medical devices, drugs, and biologics, the successful development of novel DHTs will require significant collaboration with health care stakeholders to overcome regulatory, technical, and life-cycle management challenges.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA Communication Clinic Management 52

ISPE

OCTOBER 27, 2022

As digital health sits at the intersection of technical, scientific, and regulatory disciplines involving medical devices, drugs, and biologics, the successful development of novel DHTs will require significant collaboration with health care stakeholders to overcome regulatory, technical, and life-cycle management challenges.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA HIPAA Communication 52

Pharmaceutical Technology

FEBRUARY 24, 2023

AbbVie is expanding its strategic collaboration with Capsida Biotherapeutics for the development of targeted genetic medicines to treat eye diseases with high unmet needs. Under the expanded deal terms, Capsida will take charge of capsid discovery efforts for all the programmes, along with process development and early clinical manufacturing.

Communication 52

Communication 52

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Organic compounds are arguably the foundation of the pharmaceutical industry.

Compounding 82

Compounding Pharmaceutical Companies Pharmaceutical Companies Packaging 82

ISPE

OCTOBER 26, 2022

During this 90-minute session, complementary industry perspectives from equipment/autonomous facilities providers and biopharmaceutical manufacturers will be respectively provided by Dennis Powers, Vice President, Business Development & Design Consulting, G-CON and Richard Panton, Principal Engineer, Roche/Genentech. Roche Genentech.

FDA 52

FDA 52

Pharmaceutical Technology

MAY 17, 2023

Under the deal, Prevail obtains exclusive rights to use Scribe’s CRISPR X-Editing (XE) technologies to develop the medicines. The deal will see the integration of Scribe’s new CRISPR by Design approach and Prevail’s expertise in developing genetic medicines for neurological disorders for specific genetic targets.

Immunization 52

Immunization 52

PharmaShots

FEBRUARY 27, 2023

The sole purpose of the conference was to highlight the need to develop focus of the Indian pharma industry from majorly developing generics to marking its presence for innovation for the development of new products. According to me the main issue faced during the pandemic was the supply chain of pharmaceuticals.

Packaging 40

Packaging Hospitals FDA Pharmaceutical Companies 40

ISPE

NOVEMBER 10, 2022

An interview with Shin Kawamata of Japan’s Foundation for Biomedical Research and Innovation (FBRI) highlights exciting work to move cell therapy toward reliable and scalable commercialization. Foundation for Biomedical Research and Innovation At Kobe. Pharmaceutical Engineering® recently spoke with Kawamata about his work.

Documentation 98

Documentation Compounding Hospitals Immunization 98

pharmaphorum

OCTOBER 10, 2022

In lung cancer, early detection is particularly important, as symptoms typically do not appear until the disease has already reached an advanced stage of development. TLHCs are designed to catch lung cancer during the early stages of development in asymptomatic patients with a high risk of developing the disease.

Hospitals 98

Hospitals Communication 98